Login to Your Account



Biogen's BG-12 Begins Two Phase III Trials In MS Patients

By Jennifer Boggs


Wednesday, January 10, 2007
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription